BCE
NYSE · Telecommunication
Bce Inc
$21.70
-0.29 (-1.32%)
BCE News12 articles
Canada's Q1 Deficit Narrows Sharply as Revenue Surges 9.8%
Canada's federal deficit narrowed to C$370M in Q1 as revenue surged 9.8%, but debt charges climbed 6.1%, keeping bond markets cautious.
Overbrook Fire Coverage Highlights Bell Media's Local Reach as BCE Margins Tighten
Bell Media's Q2 revenue rose 8.9% to C$918M, but margin slipped to 26.6% due to higher costs. The Overbrook fire report highlights local news' role in BCE's digital shift.
Bell Media's Q2 Revenue Surge Masks Margin Pressure at BCE
BCE's media arm posted strong Q2 revenue growth, but margin contraction and rising costs temper the outlook. CTV's standalone profitability remains undisclosed.
Canada's C$500B Summit: Bank Financing Dominates Pledges
Canada's summit pledges C$500B, but C$325B is bank financing. TD, Scotiabank, BMO lead; Bell AI hub, Maple Fund included.
Bell Canada 911 Outage Raises Network Concerns Amid Spending Surge
A fiber line outage disrupted 911 service for Bell customers in 18 Labrador communities, following a July Manitoba failure. BCE's Q2 capex surged 41.5%, while free cash flow fell 9.5%.
Rogers Faces Subscriber Growth Concerns After Richmond Fiber Outage
A fiber cut in Richmond, BC has renewed scrutiny on Rogers' network stability as Q2 internet additions fell 35%. Investors watch for impact on churn and retention.
TELUS Dividend Cut Triggers 12% Stock Drop, Yield Parity with BCE
TELUS shares tumbled 12.3% to C$13.22 after cutting its dividend by 55%, bringing its yield to 5.7% near BCE's 5.8%. The company also lowered free cash flow guidance by 27%.
TELUS Yield Surges Past 11% Amid Dividend Focus and CEO Transition
TELUS shares dropped 3.6% to C$14.46, boosting its annualized yield to 11.6%. The stock's slide comes as Victor Dodig assumes the CEO role, with investors focused on dividend stability.
TELUS shares hit new low as new CEO faces high-yield dividend challenge
TELUS shares dropped 1.77% to a new 52-week low of CA$14.71 on Thursday, as new CEO Victor Dodig takes the helm. The stock's dividend yield of 11.36% is more than double that of BCE and Rogers, highlighting the challenge of sustaining payouts.
AbCellera Surges 34% as Menopause Drug Hits Phase 2 Goals
AbCellera (ABCL) surged 34% after its menopause drug ABCL635 met Phase 2 efficacy endpoints, reducing hot flash frequency and severity with no dropouts.
AbCellera Shares Soar 37% on Promising Menopause Drug Data
AbCellera (ABCL) surged 37.5% after its menopause drug ABCL635 met all primary and secondary endpoints in a Phase 2 trial, reducing hot flash frequency by 83%.
AbCellera Shares Jump 9.7% Ahead of Key Phase 2 Data Release
AbCellera (ABCL) rose 9.7% after hours as investors await Phase 2 data for ABCL635, set to release Monday. The surge adds ~$205M to market cap.